RFA-AT-23-001 Funding Opportunity Announcement—HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)

RFA-AT-23-001 Funding Opportunity Announcement—HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)

Category of Opportunity: 
Funding - Resource

Purpose: To support multisite embedded pragmatic or implementation trials to inform the uptake of pharmacologic, nonpharmacologic, and/or multicomponent approaches for acute and/or chronic SCD pain management in health care systems that serve the SCD population.

If you have further questions, please feel free to email Dr. Wendy Weber, ([email protected]), or Dr. Sekai Chideya ([email protected]) from NCCIH or Dr. William Tonkins ([email protected]), or Dr. Susan Shero ([email protected]) from NHLBI.

NCCIH will provide a blog and technical assistance webinar on October 4, 2022 from 2:00 – 3:00 p.m. EST to better assist potential applicants understand and prepare for submission. Please register for the webinar using Eventbrite. Blog details will be forthcoming. Please see helpful FAQs and feel free to share this information with colleagues who may benefit from this research opportunity.

Deadline: 
Date and time
Application Deadline: 
Friday, October 21, 2022 - 17:00

https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-23-001.html